Smith Group Asset Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-60
| Closed | -$8K | – | 378 |
|
|
2021
Q4 | $8K | Hold |
60
| – | – | ﹤0.01% | 326 |
|
|
2021
Q3 | $8K | Hold |
60
| – | – | ﹤0.01% | 327 |
|
|
2021
Q2 | $6K | Hold |
60
| – | – | ﹤0.01% | 340 |
|
|
2021
Q1 | $4K | Sell |
60
-1,590
| -96% | -$106K | ﹤0.01% | 313 |
|
|
2020
Q4 | $141K | Sell |
1,650
-10
| -0.6% | -$855 | 0.01% | 192 |
|
|
2020
Q3 | $108K | Buy |
1,660
+520
| +46% | +$33.8K | 0.01% | 195 |
|
|
2020
Q2 | $83K | Sell |
1,140
-10
| -0.9% | -$728 | ﹤0.01% | 199 |
|
|
2020
Q1 | $39K | Hold |
1,150
| – | – | ﹤0.01% | 254 |
|
|
2019
Q4 | $63K | Hold |
1,150
| – | – | ﹤0.01% | 267 |
|
|
2019
Q3 | $48K | Buy |
+1,150
| New | +$48K | ﹤0.01% | 280 |
|